BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ELUSYS THERAPEUTICS, INC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

ELUSYS THERAPEUTICS, INC

via THE CONAFAY GROUP, LLC

1st Quarter (Jan 1 - Mar 31) · 2026Posted Apr 20, 2026Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: ELUSYS THERAPEUTICS, INC
Description: A therapeutics company that manufactures novel antitoxins for health security needs.
Location: New Jersey · United States of America

Registrant

Firm: THE CONAFAY GROUP, LLC
Description: Life Sciences Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Advocacy for medical countermeasure funding and support.
LobbyistsJOSH NARROW · mr DARIN L GARDNER · BRYAN SHUY
Covered position (JOSH NARROW): Intern to Senator Casey
Covered position (mr DARIN L GARDNER): Legislative Correspondent Senator Tim Hutchinson;ResearchAssistant Senate HELP Committee; Chief ofStaffCongresswoman Kay Granger
Covered position (BRYAN SHUY): Chief of Staff Rep. Harris; Asst. to Rep. Harris, HouseCmteon Approps; Dep. Asst. Sec and Chief of StaffHHS/Asst.Secretary for Preparedness and Response (ASPR)
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.